Abeona Therapeutics Appoints Brian Pereira and Shawn Tomasello to the Board of Directors Apr 21, 2020
Abeona Therapeutics Announces First Patient Treated in Pivotal Phase III Clinical Trial Evaluating EB-101 Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa Mar 17, 2020
Abeona Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Business Updates Mar 16, 2020
Abeona Therapeutics to Present at the 9th Annual SVB Leerink Global Healthcare Conference Feb 26, 2020
Abeona Therapeutics Announces Positive Interim Data from MPS III Gene Therapy Programs Presented at WORLDSymposium™ Feb 12, 2020
Abeona Therapeutics Announces Participation in Inaugural World Congress on Epidermolysis Bullosa Jan 21, 2020
